106 related articles for article (PubMed ID: 3307012)
1. [Effectiveness of platidiam in the chemotherapy of lymphogranulomatosis and lymphosarcoma].
Korol'chuk LV; Kruglova GV
Ter Arkh; 1987; 59(6):37-40. PubMed ID: 3307012
[No Abstract] [Full Text] [Related]
2. [Polychemotherapy of lymphosarcoma by the COP program].
Abdullaev RA; Poddubnaia IV; Shramko AF
Sov Med; 1984; (7):103-6. PubMed ID: 6385297
[No Abstract] [Full Text] [Related]
3. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
[No Abstract] [Full Text] [Related]
4. [Effectiveness of various methods of chemotherapy of lymphosarcoma].
Abdyldaev RA; Kruglova GV
Ter Arkh; 1984; 56(6):70-5. PubMed ID: 6382672
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
Crump M; Baetz T; Couban S; Belch A; Marcellus D; Howson-Jan K; Imrie K; Myers R; Adams G; Ding K; Paul N; Shepherd L; Iglesias J; Meyer R
Cancer; 2004 Oct; 101(8):1835-42. PubMed ID: 15386331
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
7. Avascular necrosis following combination chemotherapy.
Gopal R; Saikia TK; Nair CN; Nadkarni KS; Dinshaw KA; Pande SC; Mehta AR; Advani SH; Talwalkar GA
Indian J Cancer; 1985 Sep; 22(3):221-7. PubMed ID: 3843324
[No Abstract] [Full Text] [Related]
8. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
Sampi K; Maseki N; Sakurai M; Hattori M
Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
[No Abstract] [Full Text] [Related]
9. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
10. Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
Chemioterapia; 1987 Jun; 6(2 Suppl):721-3. PubMed ID: 3509941
[No Abstract] [Full Text] [Related]
11. [Liver damage in lymphoma and its clinical significance].
Pan JX
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):224-6. PubMed ID: 7505218
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.
Tseng A; Jacobs C; Coleman CN; Horning SJ; Lewis BJ; Rosenberg SA
Cancer Treat Rep; 1987 Jun; 71(6):659-60. PubMed ID: 3581106
[No Abstract] [Full Text] [Related]
13. Advances in chemotherapy for Hodgkin's and non-Hodgkin's lymphomas.
Semin Hematol; 1988 Apr; 25(2 Suppl 2):1-73. PubMed ID: 3399906
[No Abstract] [Full Text] [Related]
14. [Autologous transplant with BEAM protocol in lymphoma].
Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
[No Abstract] [Full Text] [Related]
15. Immune deficiency in malignant lymphomas.
Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
[No Abstract] [Full Text] [Related]
16. [Prognostic value of the initial remission during chemotherapy of patients with lymphosarcoma].
Kruglova GV; Abdyldaev RA
Vopr Onkol; 1985; 31(1):26-32. PubMed ID: 3838394
[TBL] [Abstract][Full Text] [Related]
17. Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
Ohnoshi T; Hayashi K; Ueoka H; Yamane T; Ueno K; Murashima M; Tada A; Yoshida M; Kimura I
Cancer Treat Rep; 1987 Jun; 71(6):639-41. PubMed ID: 3581103
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities of using polychemotherapy according to the COP protocol in lymphosarcoma of the gastrointestinal tract].
Poddubnaia IV
Ter Arkh; 1985; 57(2):103-6. PubMed ID: 3890247
[TBL] [Abstract][Full Text] [Related]
19. [Treatment and prognosis of recurrences of lymphosarcoma].
Abdyldaev RA; Kruglova GV
Ter Arkh; 1988; 60(9):71-3. PubMed ID: 3217884
[TBL] [Abstract][Full Text] [Related]
20. [Results of treatment of patients with lymphosarcoma according to the ACVP regimen].
Abdyldaev RA; Kruglova GV
Ter Arkh; 1983; 55(8):40-3. PubMed ID: 6688889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
